États-Unis · Plateformes & données · MarketBeat
Zymeworks (NASDAQ:ZYME) to Buy Back $200 million in Stock

Résumé détaillé
Zymeworks (NASDAQ:ZYME - Get Free Report) declared that its Board of Directors has approved a stock buyback plan on Monday, November 16th, RTT News reports. The company plans to buy back $200 million in outstanding shares. This repurchase authorization allows the company to buy up to 10.9% of its stock through open market purchases.
MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)



